electroCore (NASDAQ:ECOR) Shares Climb 4.3% – Should You Buy?

Shares of electroCore, Inc. (NASDAQ:ECOR) shot up 4.3% on Tuesday. The stock traded as high as $7.90 and last traded at $7.76. Approximately 62,139 shares were traded during trading, The stock had previously closed at $7.44.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of electroCore in a research note on Monday, September 21st. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $18.00.

electroCore Trading Up 4.3%

The stock’s 50-day moving average is $9.64 and its 200 day moving average is $7.70.

electroCore (NASDAQ:ECOR) last released its quarterly earnings data on Thursday, August 6th. The company reported ($0.33) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.42) by $0.09. The firm had revenue of $9.45 million for the quarter, compared to analyst estimates of $9.49 million. As a group, equities analysts anticipate that electroCore, Inc. will post -1.40 EPS for the current fiscal year.

Insider Buying and Selling at electroCore

In other electroCore news, Director Thomas Errico bought 5,000 shares of the stock in a transaction on Monday, September 14th. The shares were purchased at an average price of $9.82 per share, with a total value of $49,100.00. Following the acquisition, the director directly owned 363,904 shares of the company’s stock, valued at $3,573,537.28. This represents a 1.39% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO Joshua S. Lev sold 3,000 shares of the firm’s stock in a transaction on Tuesday, August 25th. The stock was sold at an average price of $9.36, for a total transaction of $28,080.00. Following the completion of the sale, the chief financial officer owned 84,889 shares in the company, valued at approximately $794,561.04. The trade was a 3.41% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 20,000 shares of company stock valued at $200,120. 7.80% of the stock is owned by insiders.

Institutional Investors Weigh In On electroCore

A hedge fund recently bought a new stake in electroCore stock. WealthShield Partners LLC acquired a new stake in shares of electroCore, Inc. (NASDAQ:ECOR) during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 25,978 shares of the company’s stock, valued at approximately $157,000. WealthShield Partners LLC owned 0.32% of electroCore at the end of the most recent quarter. 26.74% of the stock is owned by hedge funds and other institutional investors.

electroCore Company Profile

electroCore, Inc (NASDAQ: ECOR) is a commercial-stage medical device company focused on bioelectronic medicine and non-invasive vagus nerve stimulation (nVNS). Its technology is designed to stimulate the vagus nerve through the neck without requiring surgery or implanted components.

The company’s primary prescription product is gammaCore, a handheld nVNS device used for the acute treatment of pain associated with migraine and episodic cluster headaches in adults. electroCore also markets consumer-oriented products, including Truvaga, a handheld vagus nerve stimulation device positioned for general wellness applications.